0 Yorum
0 Paylar
98 Görüntüleme
Arama
Yeni insanlar keşfedin, yeni bağlantılar kurun ve yeni arkadaşlar edinin
-
Haber Akışı
- KEŞFEDIN
-
Sayfalar
-
Gruplar
-
Etkinlikler
-
Bloglar
-
Beğenmek, paylaşmak ve yorum yapmak için lütfen giriş yapın!
-
Biosimilars Manufacturing Market: Industry Size, Share, Biopharmaceutical Production Trends, and Forecast by 2033" According to the latest report published by Data Bridge Market Research, the Biosimilars Manufacturing Market CAGR Value As per Data Bridge Market Research Analysis The biosimilars manufacturing market was valued at USD 8.43 billion in 2025 and is projected to reach USD 16.3 billion by 2033, growing at a CAGR of 8.60% from 2026 to 2033 during the...0 Yorum 0 Paylar 136 Görüntüleme
-
Biosimilars Market Outlook 2026–2036: Trends, Segments, and ForecastBiosimilars Market to Reach USD 73.24 Billion by 2036: What Is Driving Growth Healthcare systems around the world are under pressure to deliver advanced therapies at lower cost. Biologic medicines treat cancer, autoimmune disorders, and eye diseases, but their high prices strain budgets. This is where the Biosimilars Market is making a real difference. By offering highly similar alternatives...0 Yorum 0 Paylar 244 Görüntüleme
-
Biosimilars Market Technology Trends Reshaping Biologic Drug Development 2028The Biosimilars Market is benefiting from the expiration of exclusivity periods for major biologic medicines. This is encouraging pharmaceutical manufacturers to develop biosimilar versions of established therapies and compete in previously protected therapeutic segments. The Biosimilars Market size is expected to grow from US$ 18,435.89 million in 2021 to US$ 136,069.53 million by 2028,...0 Yorum 0 Paylar 95 Görüntüleme
-
Biosimilars Market Trends: Why Patent Expirations Are Creating New Opportunities for Biosimilar DrugsBiosimilars Market: Interchangeability, Patent Expiry and the Checkpoint Inhibitor Pipeline The Biosimilars Market comprises biological medicines shown to be highly similar to an already approved reference biologic, with no clinically meaningful differences in safety, purity or potency. In the US, they are approved through the abbreviated 351(k) pathway established under the Biologics Price...0 Yorum 0 Paylar 54 Görüntüleme
-
Herceptin Biosimilars Market Size, Share, Trends, Industry Analysis and Forecast to 2030"Herceptin Biosimilars Market Summary: According to the latest report published by Data Bridge Market Research, the Herceptin Biosimilars Market CAGR Value Data Bridge Market Research analyses that the market which was USD 1,810 million in 2022, would rocket up to USD 11,302 million by 2030 and is expected to undergo a CAGR of 23.2% during the forecast period. ...0 Yorum 0 Paylar 478 Görüntüleme
-
Herceptin Biosimilars Market Size, Share, Trends, Industry Growth and Forecast by 2033"Executive Summary Herceptin Biosimilars Market Size and Share Across Top Segments CAGR Value Data Bridge Market Research analyses that the market which was USD 1,810 million in 2022, would rocket up to USD 11,302 million by 2030 and is expected to undergo a CAGR of 23.2% during the forecast period. To better structure this Herceptin Biosimilars report, a nice blend of...0 Yorum 0 Paylar 614 Görüntüleme
-
Herceptin Biosimilars Market: Industry Size, Share, Oncology Biologics & Breast Cancer Therapeutics Trends, and Forecast by 2030" According to the latest report published by Data Bridge Market Research, the Herceptin Biosimilars Market CAGR Value Data Bridge Market Research analyses that the market which was USD 1,810 million in 2022, would rocket up to USD 11,302 million by 2030 and is expected to undergo a CAGR of 23.2% during the forecast period. All the data and information included in the...0 Yorum 0 Paylar 87 Görüntüleme
-
Oncology Immunotherapy Biosimilars Market Analysis: Top Trends Defining Future Industry Success" According to the latest report published by Data Bridge Market Research, the Oncology Immunotherapy Biosimilars Market The global Oncology Immunotherapy Biosimilars market size was valued at USD 891 Million in 2025 and is expected to reach USD 1828.16 Million by 2033, at a CAGR of 9.40% during the forecast period. Oncology Immunotherapy Biosimilars Market report has been...0 Yorum 0 Paylar 338 Görüntüleme
-
Ophthalmology Anti-VEGF Biosimilars Market Shares, Demand, and Growth Trends 2033"Executive Summary Ophthalmology Anti-VEGF Biosimilars Market: Share, Size & Strategic Insights CAGR Value The global ophthalmology Anti-VEGF biosimilars market size was valued at USD 475.2 Million in 2025 and is expected to reach USD 958.74 Million by 2033, at a CAGR of 9.17% during the forecast period The Ophthalmology Anti-VEGF Biosimilars...0 Yorum 0 Paylar 725 Görüntüleme
-
Recombinant Hormone Biosimilars Market Innovation Trends Unlocking Long-Term Growth Potential" According to the latest report published by Data Bridge Market Research, the Recombinant Hormone Biosimilars Market The global recombinant hormone biosimilars market size was valued at USD 217.80 million in 2025 and is expected to reach USD 460.12 million by 2033, at a CAGR of 9.80% during the forecast period An international Recombinant Hormone...0 Yorum 0 Paylar 364 Görüntüleme
Diğer Sonuçlar
Sponsor
